Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Discacciati

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
European Urology Open Science|April 24, 2023
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate CancerAnna Lantz, Per Nordlund, Ugo Falagario, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 20, 2016
Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interactionMarco Moltrasio, Nicola Cosentino, Monica De Metrio, et al.
European Urology Focus|July 30, 2025
Prostate-specific Antigen Density as a Selection Tool Before Magnetic Resonance Imaging in Prostate Cancer Screening: An Analysis from the STHLM3MRI Randomized Clinical TrialLars Björnebo, Andrea Discacciati, Ahmad Abbadi, et al.
Journal of the National Cancer Institute|May 8, 2024
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonistsLars Björnebo, Shirin Razdan, Andrea Discacciati, et al.
American Heart Journal|December 15, 2010
Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary interventionGiancarlo Marenzi, Monica De Metrio, Mara Rubino, et al.
British Journal of Cancer|May 6, 2023
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy womenMattias Hammarström, Marike Gabrielson, Alessio Crippa, et al.
European Urology Open Science|November 24, 2025
Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial EmulationAhmad Abbadi, Chiara Micoli, Andrea Discacciati, et al.
Communications Medicine|March 24, 2026
Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
CHEST Critical Care|June 4, 2025
Anti-CD14 treatment in patients with severe COVID-19: Clinical and biological effects in a Phase 2 randomized open-label adaptive platform clinical trialF Linzee Mabrey, Thomas R Martin, Carolyn S Calfee, et al.
Communications Medicine|October 30, 2025
Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
European Urology Open Science|April 24, 2023
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate CancerAnna Lantz, Per Nordlund, Ugo Falagario, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 20, 2016
Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interactionMarco Moltrasio, Nicola Cosentino, Monica De Metrio, et al.
European Urology Focus|July 30, 2025
Prostate-specific Antigen Density as a Selection Tool Before Magnetic Resonance Imaging in Prostate Cancer Screening: An Analysis from the STHLM3MRI Randomized Clinical TrialLars Björnebo, Andrea Discacciati, Ahmad Abbadi, et al.
Journal of the National Cancer Institute|May 8, 2024
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonistsLars Björnebo, Shirin Razdan, Andrea Discacciati, et al.
American Heart Journal|December 15, 2010
Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary interventionGiancarlo Marenzi, Monica De Metrio, Mara Rubino, et al.
British Journal of Cancer|May 6, 2023
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy womenMattias Hammarström, Marike Gabrielson, Alessio Crippa, et al.
European Urology Open Science|November 24, 2025
Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial EmulationAhmad Abbadi, Chiara Micoli, Andrea Discacciati, et al.
Communications Medicine|March 24, 2026
Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
CHEST Critical Care|June 4, 2025
Anti-CD14 treatment in patients with severe COVID-19: Clinical and biological effects in a Phase 2 randomized open-label adaptive platform clinical trialF Linzee Mabrey, Thomas R Martin, Carolyn S Calfee, et al.
Communications Medicine|October 30, 2025
Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
Pageof 8